A Randomized, Open-label, Single Dose, 2-period, 2-treatment, Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of CKD-379 and Coadministration of D759, D745 and D150 in Healthy Subjects
Latest Information Update: 15 May 2023
At a glance
- Drugs Empagliflozin/Metformin/Sitagliptin (Primary) ; D 759
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
Most Recent Events
- 10 May 2023 Status changed from not yet recruiting to completed.
- 10 Feb 2023 New trial record